In this study, we discovered CPEB1 as a key regulator controlling NRF2 proteostasis and ferroptosis susceptibility in pancreatic cancer, and established the clinical significance of CPEB1 in predicting therapeutic outcomes. Here, NFE2L2 is linked to familial pancreatic carcinoma.